Skip to main content
NVDA-2.44%AAPL+3.15%GOOGL+0.44%MSFT-0.14%AMZN-0.22%TSM-1.32%SPCX+0.84%AVGO-0.58%META-1.20%TSLA-0.40%SKHY-4.06%MU-4.40%BRK-B-0.25%LLY-0.13%JPM-0.68%WMT-0.14%AMD-3.07%V-0.22%XOM+0.64%ASMLa-1.66%JNJ-0.16%INTC-4.61%MA-0.60%0700.HK-1.94%1398.HK+0.79%ORCL-3.99%ABBV+0.96%BAC-0.52%CSCO-1.09%CVX-0.39%COST-0.17%KO+0.61%LRCX-4.98%CAT-1.42%AP2d-1.55%0005.HK-0.78%AMAT-2.60%UNH-1.05%HSBA.L-1.30%DELL-3.48%PG+0.46%MS-1.08%GE-0.65%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.26%HD-1.88%0939.HK+1.66%GS-1.16%NZDJPY-2.62%AUDJPY-1.83%CHFJPY-1.60%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.25%USDJPY-1.23%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.97%USDNOK+0.91%USDSEK+0.88%AUDNZD+0.82%EURZAR+0.80%EURNOK+0.73%GBPZAR+0.72%EURSEK+0.71%AUDCAD-0.69%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.61%USDTHB+0.60%CHFNOK+0.57%GBPAUD+0.57%CHFSEK+0.55%AUDSGD-0.54%USDMXN+0.51%USDPLN+0.43%NZDSGD-0.42%CADCHF+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.27%EURPLN+0.26%SGDJPY+0.24%AUDCHF-0.23%NZDMXN-0.21%EURHKD-0.18%USDDKK+0.17%USDILS+0.16%USDTRY+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%AUDNOK+0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%EURCNH-0.05%EURCZK-0.05%USDCAD-0.05%USDCOP-0.04%EURGBP+0.04%GBPUSD-0.02%USDHKD+0.02%GBPSGD+0.02%EURUSD0.00%EURDKK0.00%XPTUSD-5.92%XAGUSD-5.06%GAGUSD-5.06%UKOIL+4.96%HG1-4.82%USOIL+4.74%XNGUSD+1.63%GAUUSD-1.55%XAUUSD-1.55%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.37%ETHUSD-0.03%USDTUSD-0.02%XRPUSD-2.84%SOLUSD-1.64%TRXUSDT+0.24%ZECUSDT-8.36%DOGEUSD-2.56%XMRUSDT+0.47%LINKUSD-1.12%XLMUSD-1.17%BCHUSDT-9.67%LTCUSD-1.50%UNIUSD-1.03%TONUSD+24.88%HBARUSDT-2.32%SUIUSD-3.99%TAOUSDT-5.17%AAVEUSD-2.21%DOTUSDT-1.56%ICPUSDT-0.72%ONDOUSDT-2.95%WLDUSDT-2.43%ATOMUSDT-2.11%ARBUSDT+0.11%JUPUSDT-3.39%INJUSDT-1.83%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-0.97%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.05%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.41%IOTAUSDT-3.42%AXSUSDT-2.25%FARTCOINUSDT-2.86%EOSUSDT-2.41%DYDXUSDT-1.72%ORDIUSDT-0.35%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%NVDA-2.44%AAPL+3.15%GOOGL+0.44%MSFT-0.14%AMZN-0.22%TSM-1.32%SPCX+0.84%AVGO-0.58%META-1.20%TSLA-0.40%SKHY-4.06%MU-4.40%BRK-B-0.25%LLY-0.13%JPM-0.68%WMT-0.14%AMD-3.07%V-0.22%XOM+0.64%ASMLa-1.66%JNJ-0.16%INTC-4.61%MA-0.60%0700.HK-1.94%1398.HK+0.79%ORCL-3.99%ABBV+0.96%BAC-0.52%CSCO-1.09%CVX-0.39%COST-0.17%KO+0.61%LRCX-4.98%CAT-1.42%AP2d-1.55%0005.HK-0.78%AMAT-2.60%UNH-1.05%HSBA.L-1.30%DELL-3.48%PG+0.46%MS-1.08%GE-0.65%3988.HK+0.84%1816.HK+0.23%0857.HK-3.26%NFLX-0.26%HD-1.88%0939.HK+1.66%GS-1.16%NZDJPY-2.62%AUDJPY-1.83%CHFJPY-1.60%NZDCAD-1.47%EURNZD+1.44%NZDUSD-1.42%GBPNZD+1.39%GBPJPY-1.25%USDJPY-1.23%EURJPY-1.23%CADJPY-1.17%NZDCHF-1.05%USDZAR+0.97%USDNOK+0.91%USDSEK+0.88%AUDNZD+0.82%EURZAR+0.80%EURNOK+0.73%GBPZAR+0.72%EURSEK+0.71%AUDCAD-0.69%AUDDKK-0.64%EURAUD+0.61%AUDUSD-0.61%USDTHB+0.60%CHFNOK+0.57%GBPAUD+0.57%CHFSEK+0.55%AUDSGD-0.54%USDMXN+0.51%USDPLN+0.43%NZDSGD-0.42%CADCHF+0.42%GBPTRY+0.41%NOKJPY-0.40%USDCHF+0.38%EURCHF+0.37%GBPCHF+0.34%GBPHKD+0.32%GBPMXN-0.28%USDSGD+0.27%EURPLN+0.26%SGDJPY+0.24%AUDCHF-0.23%NZDMXN-0.21%EURHKD-0.18%USDDKK+0.17%USDILS+0.16%USDTRY+0.11%EURSGD+0.10%USDCNH+0.10%GBPCAD-0.09%AUDNOK+0.09%PLNJPY+0.08%CHFSGD-0.06%EURCAD-0.06%EURCNH-0.05%EURCZK-0.05%USDCAD-0.05%USDCOP-0.04%EURGBP+0.04%GBPUSD-0.02%USDHKD+0.02%GBPSGD+0.02%EURUSD0.00%EURDKK0.00%XPTUSD-5.92%XAGUSD-5.06%GAGUSD-5.06%UKOIL+4.96%HG1-4.82%USOIL+4.74%XNGUSD+1.63%GAUUSD-1.55%XAUUSD-1.55%SUGAR0.00%S10.00%COFFEE0.00%BTCUSD-1.37%ETHUSD-0.03%USDTUSD-0.02%XRPUSD-2.84%SOLUSD-1.64%TRXUSDT+0.24%ZECUSDT-8.36%DOGEUSD-2.56%XMRUSDT+0.47%LINKUSD-1.12%XLMUSD-1.17%BCHUSDT-9.67%LTCUSD-1.50%UNIUSD-1.03%TONUSD+24.88%HBARUSDT-2.32%SUIUSD-3.99%TAOUSDT-5.17%AAVEUSD-2.21%DOTUSDT-1.56%ICPUSDT-0.72%ONDOUSDT-2.95%WLDUSDT-2.43%ATOMUSDT-2.11%ARBUSDT+0.11%JUPUSDT-3.39%INJUSDT-1.83%STXUSDT-4.16%FETUSDT-2.62%TIAUSDT-0.34%PYTHUSDT-0.97%SEIUSDT-6.02%IMXUSDT-3.06%GRTUSDT-3.05%WIFUSDT-4.89%OPUSDT-3.00%POLUSDT-4.41%IOTAUSDT-3.42%AXSUSDT-2.25%FARTCOINUSDT-2.86%EOSUSDT-2.41%DYDXUSDT-1.72%ORDIUSDT-0.35%GALAUSDT-3.09%NOTUSDT-2.97%RONINUSDT-2.64%
AL

Alumis Inc. (ALMS)

NASDAQ • Healthcare

$9.8
-$0.77 (-7.4%)
Market open

Last close at September 9, 2026 at 20:00 UTC

Open$10.49
Previous Close$9.8
Day Range$9.77 - $10.67
Avg. Volume (3M)3.4M
Market Cap$1.2B
52 Week Range
$3.76$31.35
Next EarningsIn 63 daysNov 12, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$1.6M100%
Gross Profitminus cost of goods$1.6M100%

Fundamentals & Financials

Revenue (TTM)
$7.3M
Net Income (TTM)
-$438.9M
EPS (TTM)
-$3.8
ROA (TTM)
-78.3%
Current Ratio
6.74

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+2.1%Q1 2026-$0.95
+0.4%Q2 2026-$0.74
-44.7%Q3 2026-$1.11
Next

Nov 12

in 63 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

View full earnings history

About Alumis Inc.

Alumis Inc. is a NASDAQ-listed biotechnology company developing and aiming to commercialize medicines for autoimmune disorders. In FY2025, the company recorded $24.1 million in revenue. Its work centers on immune-pathway drug candidates that span autoimmune disease, central nervous system inflammation, and related immune dysfunction.

Name
Alumis Inc.
CEO
Martin Babler
Website
www.alumis.com
Industry
Healthcare
Year Founded
2021
Employees
237

Today's Snapshot

AI-generated

ALMS is trading 0.6% higher at 9.86, while its sector was flat.

Trading Volume

Below 10d avg (6.2M)

2.1M

vs S&P 500 Today

Outperforming Market

+1.18%

Updated: September 10, 2026 at 17:09 UTC

Technical Indicators

2 Buy0 Neutral6 Sell
ALMS exhibits a pronounced bearish structure: price is well below short- and long-term moving averages, MACD is strongly negative, and the ADX indicates a robust downtrend, while on-balance volume signals distribution. Some oscillators read as oversold, but momentum remains negative and intraday VWAP lies above the current price, reinforcing downward bias. Volatility is high by ATR, underscoring large intraday moves during the decline. Technical takeaway: Strong Sell — a strong downtrend with elevated volatility and negative volume confirms sustained selling pressure.
All signals
  • EMA (5 indicators)$13.52 - $22.52
    Sell
  • RSI (14)21.96
    Buy
  • Stochastic %K (14, 3, 3)8.06
    Buy
  • MACD Level (12, 26)-4.32
    Sell

Peers & Related Assets

ETONEton Pharmaceuticals, Inc.
$58.83-0.9%
OMEROmeros Corporation
$19.39+1.4%
FULCFulcrum Therapeutics, Inc.
$3.84+0.5%
ADCTADC Therapeutics S.A.
$1.22-6.2%
RAPTRAPT Therapeutics, Inc.
LXRXLexicon Pharmaceuticals, Inc.
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.